-- CARE Ratings assigned AA+ rating to Mankind Pharma's (NSE:MANKIND, BOM:543904) long-term bank facilities and A1+ rating to the short-term bank facilities of the pharmaceutical company, according to an Indian bourse filing on Wednesday.
Shares of the company rose nearly 3% in Thursday's trade.
The rating outlook is stable.